Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy.

EditorÐSchmidt and colleagues should be congratulated for their case presentation and the patient's good outcome. We appreciated the detailed discussion on Duchenne muscular dystrophy (DMD) and perioperative complications. It is striking that preoperative echocardiography may not re ̄ect the intraoperative ability of the diseased myocardium to respond to stressÐa situation we are quite often confronted with in clinical scenarios. The authors raise the question of which intraoperative monitoring should be used for detection of cardiac abnormalities and for adjusting therapy. From our point of view the patient was adequately monitored, at least at the beginning of the operation. Nevertheless, we are surprised that the high arteriovenous PCO2 difference of 15 mm Hg, 30 min after induction of anaesthesia (Fig. 2 of Case Report 1) was not mentioned in the discussion. Given a normal ventilatory situation, should this difference not be interpreted as a hallmark of early cardiac decompensation? Carried forward to anaesthetic practice generally, an increased arteriovenous PCO2 difference demands clari®cation, and should be the trigger for more invasive haemodynamic monitoring such as transoesophageal echocardiography, pulmonary artery catheterization or pulse contour analysis.

[1]  F. Wappler,et al.  Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy. , 2003, British journal of anaesthesia.

[2]  J. Antognini,et al.  Testing for Malignant Hyperthermia , 2002, Anesthesiology.

[3]  G. Gronert Cardiac Arrest after Succinylcholine: Mortality Greater with Rhabdomyolysis Than Receptor Upregulation , 2001, Anesthesiology.

[4]  K. Kleopa,et al.  Malignant hyperthermia-like episode in Becker muscular dystrophy. , 2000, Anesthesiology.

[5]  H. Ørding,et al.  Between-Center Variability of Results of the In Vitro Contracture Test for Malignant Hyperthermia Susceptibility , 2000, Anesthesia and analgesia.

[6]  A. Takagi [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers]. , 2000, Rinsho shinkeigaku = Clinical neurology.

[7]  U. Schara,et al.  [Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types]. , 2000, Der Anaesthesist.

[8]  H. Gilly,et al.  Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study. , 1997, British journal of anaesthesia.

[9]  J. Reed,et al.  The relationship between the arteriovenous carbon dioxide gradient and cardiac index. , 1993, Journal of critical care.

[10]  J. Vincent,et al.  Arteriovenous differences in PCO2 and pH are good indicators of critical hypoperfusion. , 1993, The American review of respiratory disease.

[11]  J. Vincent,et al.  Veno-arterial carbon dioxide gradient in human septic shock. , 1992, Chest.

[12]  W. Ellis,et al.  Absence of malignant hyperthermia contractures in Becker‐Duchenne dystrophy at age 2 , 1992, Muscle & nerve.

[13]  O. Hein-Sørensen,et al.  Complications during anaesthesia in patients with Duchenne’s muscular dystrophy (a retrospective study) , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  M. Rockoff,et al.  Anesthesia-related complications in children with Duchenne muscular dystrophy. , 1988, Anesthesiology.

[15]  A. Brownell Malignant hyperthermia: relationship to other diseases. , 1988, British journal of anaesthesia.

[16]  K. Ikeda,et al.  Malignant hyperpyrexia and duchenne muscular dystrophy: A case report , 1982, Canadian Anaesthetists' Society journal.

[17]  M. Sussman,et al.  Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. , 1978, Anesthesiology.